Viral Vector Manufacturing Industry 2025: Industrial Growth, Future Scope, Market Share, Investment

Viral Vector Manufacturing Market reached USD 0.9Bn in 2022 and is expected to reach USD 3.8Bn by 2031 growing with a CAGR of 20.3% during the forecast period 2024-2031.

United States: Recent Industry Developments

✅ November 2025: Thermo Fisher Scientific expanded viral vector production capacity in its Massachusetts facility to support late-stage gene therapy programs.
✅ October 2025: Catalent announced advancements in high-yield AAV vector manufacturing platforms to reduce production time and cost.

Japan: Recent Industry Developments

✅ November 2025: Takara Bio opened a next-generation viral vector manufacturing suite dedicated to CAR-T and gene therapy development.
✅ October 2025: Astellas Pharma invested in in-house AAV vector capabilities to reduce dependency on CDMOs and accelerate clinical development.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/viral-vector-manufacturing-market?kb

Key Players:

Sanofi SA, Thermo Fisher Scientific Inc., Cobra Biologics Ltd, Lonza Group Ltd, Merck & Co., Oxford BioMedica, CGT Catapult, UniQure NV, FUJIFILM Diosynth Biotechnologies, and Spark Therapeutics Inc.

Latest Drugs and Product Launches

✅ Merck KGaA launched advanced viral vector production platforms improving scalability and product consistency for CAR-T therapies and other gene therapies.​

✅ ArcticZymes Technologies introduced GMP-grade nucleases specifically designed for viral vector manufacturing, facilitating cleaner and more efficient gene therapy production processes.

Growth Forecast Projection:

The Global Viral Vector Manufacturing Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Viral Vector Manufacturing Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=viral-vector-manufacturing-market?kb

Key Segmentation:

By Type: (Retroviral Vectors, Adenoviral Vectors, Adeno-Associated Viral Vectors, Other Viral Vectors)

By Disease: (Cancer, Genetic Disorders, Infectious Diseases, Other Diseases)

By Application: (Gene Therapy, Vaccinology)

By End User: (Pharmaceutical and Biopharmaceutical Companies, Research Institutes

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Viral Vector Manufacturing producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Viral Vector Manufacturing revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/viral-vector-manufacturing-market?kb

Latest Clinical Trials

✅ Viral vector manufacturing advancements improve supply for phase 3 and pivotal trials for diseases including rare inherited disorders, hemophilia, and cancer immunotherapy.​

✅ Several clinical evaluations in Japan and the USA utilize GMP-produced viral vectors enabling gene therapies with improved safety profiles and dosing regimens.

Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/viral-vector-manufacturing-market?kb

Latest Project Hubs

✅ USA hubs for viral vector manufacturing include Carlsbad (Merck, Thermo Fisher), Longmont (AGC Biologics), New York Centers (Roswell Park Cancer Center expansion), and emerging gene therapy clusters in Boston and San Francisco Bay Area.​

✅ Japan focuses on expanding CDMOs and academic-industry partnerships in Tokyo, Osaka, and Nagoya regions, with new GMP viral vector facilities and substantial government backing, advancing personalized and cell therapy manufacturing networks.

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.